{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:18:09Z","timestamp":1785449889618,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"MICINN","doi-asserted-by":"publisher","award":["PID2021-126304OB-C41"],"award-info":[{"award-number":["PID2021-126304OB-C41"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["ACIF\/2020"],"award-info":[{"award-number":["ACIF\/2020"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["CIPROM\/2021\/007"],"award-info":[{"award-number":["CIPROM\/2021\/007"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.nbd.2023.106312","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T11:45:29Z","timestamp":1695728729000},"page":"106312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease"],"prefix":"10.1016","volume":"187","author":[{"given":"Marina","family":"Botello-Marabotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Mart\u00ednez-Bisbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernardos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Mart\u00ednez-M\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106312_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/CIA.S239350","article-title":"Circulating glutamine and Alzheimer\u2019s disease: a mendelian randomization study","volume":"15","author":"Adams","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.nbd.2023.106312_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejor.2009.03.050","article-title":"Improving discrimination in data envelopment analysis: PCA-DEA or variable reduction","volume":"202","author":"Adler","year":"2010","journal-title":"Eur. J. Oper. Res."},{"key":"10.1016\/j.nbd.2023.106312_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0502-1","article-title":"Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression","volume":"13","author":"Albanese","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2023.106312_bb0020","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2023.106312_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106312_bb0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2023.106312_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.adg6275","article-title":"Alzheimer\u2019s drug approval gets a mixed reception: FDA allows use of antibody despite ongoing debates over its benefits and dangers","volume":"379","author":"Couzin-Frankel","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.nbd.2023.106312_bb0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.drudis.2010.06.012","article-title":"Cell culture metabolomics: applications and future directions","volume":"15","author":"\u010cuperlovi\u0107-Culf","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.nbd.2023.106312_bb0045","first-page":"19","article-title":"Clinical metabolomics: the next stage of clinical biochemistry","volume":"10","author":"D\u2019Alessandro","year":"2012","journal-title":"Blood Transfus."},{"key":"10.1016\/j.nbd.2023.106312_bb0050","first-page":"183","article-title":"Generalization of results from cognitive stimulation programs to real life is it possible?","volume":"2","author":"D\u00edaz-Orueta","year":"2010","journal-title":"Alzheimer\u2019s Dis. Res. J."},{"key":"10.1016\/j.nbd.2023.106312_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/9781118656082.ch6","article-title":"Mild cognitive impairment","author":"Duara","year":"2013","journal-title":"Dementia"},{"key":"10.1016\/j.nbd.2023.106312_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpba.2013.09.025","article-title":"NMR metabolomics of human blood and urine in disease research","volume":"93","author":"Duarte","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.nbd.2023.106312_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-181189","article-title":"Serum metabolite markers of dementia through quantitative NMR analysis: the importance of threonine-linked metabolic pathways","volume":"69","author":"Figueira","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo6010011","article-title":"Evaluation of cancer metabolomics using ex vivo high resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS)","volume":"6","author":"Fuss","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.nbd.2023.106312_bb0075","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2023.106312_bb0080","article-title":"World Alzheimer Report 2021: Journey through the diagnosis of dementia","author":"Gauthier","year":"2021","journal-title":"Alzheimer\u2019s Dis. Int."},{"key":"10.1016\/j.nbd.2023.106312_bb0085","first-page":"1","article-title":"Why 70\/30 or 80\/20 relation between training and testing sets: a pedagogical explanation","volume":"1209","author":"Gholamy","year":"2018","journal-title":"Dep. Tech. Rep."},{"key":"10.1016\/j.nbd.2023.106312_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nbd.2023.106312_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00002093-200007000-00008","article-title":"The severe mini-mental state examination: a new neuropsychologic instrument for the bedside assessment of severely impaired patients with Alzheimer disease","volume":"14","author":"Harrell","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.nbd.2023.106312_bb0100","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.14336\/AD.2019.0611","article-title":"Aging, Alzheimer\u2019s disease and dysfunctional glycolysis; similar effects of too much and too little","volume":"10","author":"Hipkiss","year":"2019","journal-title":"Aging Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0105","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/ac301243k","article-title":"Toward a predictive model of Alzheimer\u2019s disease progression using capillary electrophoresis-mass spectrometry metabolomics","volume":"84","author":"Ib\u00e1\u00f1ez","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.nbd.2023.106312_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-191226","article-title":"Metabolic profiles help discriminate mild cognitive impairment from dementia stage in Alzheimer\u2019s disease","volume":"74","author":"J\u00e4\u00e4skel\u00e4inen","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10555-013-9489-6","article-title":"Emerging technology: applications of Raman spectroscopy for prostate cancer","volume":"33","author":"Kast","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.nbd.2023.106312_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78031-9","article-title":"Urinary metabolic phenotyping for Alzheimer\u2019s disease","volume":"10","author":"Kurbatova","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106312_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.2022.24494","article-title":"Lecanemab gains FDA approval for early Alzheimer disease","volume":"329","author":"Larkin","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.nbd.2023.106312_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-210461","article-title":"Phenylalanine metabolism is dysregulated in human hippocampus with Alzheimer\u2019s disease related pathological changes","volume":"83","author":"Liu","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0135","doi-asserted-by":"crossref","first-page":"105031","DOI":"10.1016\/j.nbd.2020.105031","article-title":"It\u2019s complicated: the relationship between sleep and Alzheimer\u2019s disease in humans","volume":"144","author":"Lucey","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/nbm.888","article-title":"1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas","volume":"17","author":"Mart\u00ednez-Bisbal","year":"2004","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nbd.2023.106312_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2023.106312_bb0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2023.106312_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.chemolab.2012.07.010","article-title":"A review of variable selection methods in partial least squares regression","volume":"118","author":"Mehmood","year":"2012","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.nbd.2023.106312_bb0160","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/gps.4915","article-title":"Dealing with severe dementia in clinical practice: a validity and reliability study of severe Mini-mental state examination in Greek population","volume":"33","author":"Mougias","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106312_bb0165","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","article-title":"Alzheimer\u2019s disease: natural products as inhibitors of neuroinflammation","volume":"28","author":"Olajide","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.nbd.2023.106312_bb0170","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer\u2019s disease","volume":"45","author":"Olazar\u00e1n","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archneur.1996.00550040107020","article-title":"Neuropsychological assessment of severely demented elderly: the severe cognitive impairment profile","volume":"53","author":"Peavy","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2023.106312_bb0180","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s13238-015-0185-x","article-title":"Functional metabolomics: from biomarker discovery to metabolome reprogramming","volume":"6","author":"Peng","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.nbd.2023.106312_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2023.106312_bb0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/d41586-023-00030-3","article-title":"FDA approves Alzheimer\u2019s drug amid safety concerns","volume":"613","author":"Reardon","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106312_bb0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0197-0186(99)00150-3","article-title":"Neuronal expression of glutamine synthetase in Alzheimer\u2019s disease indicates a profound impairment of metabolic interactions with astrocytes","volume":"36","author":"Robinson","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2023.106312_bb0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106312_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bmc.4875","article-title":"Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC\/MS","volume":"34","author":"Sun","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.nbd.2023.106312_bb0210","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/acs.jproteome.9b00850","article-title":"Fingerprinting Alzheimer\u2019s disease by 1H nuclear magnetic resonance spectroscopy of cerebrospinal fluid","volume":"19","author":"Vignoli","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2023.106312_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11306-010-0200-4","article-title":"An inter-laboratory comparison demonstrates that [1H]-NMR metabolite fingerprinting is a robust technique for collaborative plant metabolomic data collection","volume":"6","author":"Ward","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.nbd.2023.106312_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2023.106312_bb0225","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.metabol.2014.10.034","article-title":"Biomarkers in the diagnosis and management of Alzheimer\u2019s disease","volume":"64","author":"Wurtman","year":"2015","journal-title":"Metabolism."},{"key":"10.1016\/j.nbd.2023.106312_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2020.530219","article-title":"Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease","volume":"14","author":"Yan","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2023.106312_bb0235","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3233\/JAD-200305","article-title":"A community-based study identifying metabolic biomarkers of mild cognitive impairment and Alzheimer\u2019s disease using artificial intelligence and machine learning","volume":"78","author":"Yilmaz","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106312_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-022-01004-9","article-title":"Cerebrospinal fluid lactate levels along the Alzheimer\u2019s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers","volume":"14","author":"Zebhauser","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2023.106312_bb0245","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/acs.jproteome.8b00847","article-title":"Tissue-specific metabolomics analysis identifies the liver as a major organ of metabolic disorders in amyloid precursor protein\/Presenilin 1 mice of Alzheimer\u2019s disease","volume":"18","author":"Zheng","year":"2019","journal-title":"J. Proteome Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123003285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123003285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:27Z","timestamp":1760852367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123003285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"alternative-id":["S0969996123003285"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106312","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106312"}}